CAPS Intrinsic Valuation and Fundamental Analysis - Capstone Therapeutics Corp

	Capstone Therapeutics Corp OTC:CAPS	US

Intrinsic Value

CAPS latest financial reports are more than 3 years old.

CAPS doesn't have a meaningful market cap.

The intrinsic value for Capstone Therapeutics Corp (CAPS) under the Base Case is 0.2249 USD. Compared with the current market price of 0.1933 USD, the stock appears Undervalued by 14% .

Intrinsic value calculated using DCF

$0.2249

Do our valuations actually work? See backtest results .

CAPS Intrinsic Value

Undervaluation 14%

Intrinsic Value

Price $0.1933

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value $0.18

Get notified when the price drops into your buy zone

Intrinsic Value $0.22

Current Price $0.19

Margin of Safety 20% $0.18

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Capstone Therapeutics Corp.

Explain Valuation